Accessibility Menu
AdaptHealth logo

AdaptHealth(NASDAQ) AHCO

Market Cap$767.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2019)-41%
5 Year-77%
1 Year-41%
1 Month-48%
Premium Feature
Moneyball Superscore
50/100
$5.62
-0.27%
-0.01Today
After hours$5.63+$0.01 (+0.18%)
AdaptHealth last closing stock price
MetricPriceDate
Last closeUSD 5.632026-08-24
AdaptHealth stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-3.1%USD 5.812026-08-17
1 month-47.68%USD 10.762026-07-24
3 month-45.66%USD 10.362026-05-26
Year to date-43.47%USD 9.962025-12-31
1 year-41.42%USD 9.612025-08-22
3 year-51.51%USD 11.612023-08-25
5 year-76.59%USD 24.052021-08-25
Since inception-41.35%USD 9.602019-11-11

AdaptHealth Financials at a Glance

Market Cap

$767.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$3.01B

Net Income (TTM)

-$228.23M

EPS (TTM)

-$1.68

P/E Ratio

-3.36

Dividend

$0.00

Beta (Volatility)

0.93 (Low)

Price

$5.62

Volume

119

Open

$5.63

Previous Close

$5.63

Daily Range

$5.56 - $5.66

52-Week Range

$5.21 - $13.43

Estimated Earnings Date

Nov 3, 2026

AHCO: Motley Fool Moneyball Superscore

50

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About AdaptHealth

AdaptHealth Corp. helps people get medical equipment at home. It provides tools for sleep and breathing problems. The company serves millions of patients in the United States.

Tools for Health at Home

  • Sleep Health: Therapy equipment and supplies for sleep apnea, such as continuous positive airway pressure (CPAP) machines; 52.2% of revenue in the three months ended June 30, 2026.
  • Respiratory Health: Oxygen and home mechanical ventilation equipment for patients with chronic lung diseases; 26.3% of revenue in the three months ended June 30, 2026.
  • Wellness at Home: Home medical equipment (HME) and supplies for patients transitioning from hospital care; 21.5% of revenue in the three months ended June 30, 2026.

Strategic Moves and Sales

  • Agreed to sell the Diabetes Health business for $235.0 million in cash in July 2026.
  • Refinanced debt in April 2026 by entering a new $1.1 billion credit agreement.
  • Launched a restructuring plan in June 2026 to optimize resources and reduce headcount.
  • Expanded at-risk insurance contracts, which provide fixed monthly fees, starting in the third quarter of 2025.

A National Care Network

AdaptHealth services approximately 4.8 million patients annually through a network of 670 locations in 48 states. The company uses a digital platform for orders to drive efficiency and manage rising inflationary costs.

Key Financial Results

  • Net revenue was $740.3 million in the three months ended June 30, 2026, up 12.7% year over year.
  • Net loss attributable to the company was $145.3 million in the three months ended June 30, 2026.
  • Non-cash goodwill impairment charges totaled $144.2 million during the second quarter of 2026.
  • Working capital for continuing operations was negative $79.3 million as of June 30, 2026.
  • Free cash flow was negative $48.4 million for the six months ended June 30, 2026.

The Evolution of Care

AdaptHealth has focused on expanding at-risk insurance contracts while divesting noncore business units like diabetes care. The company is prioritizing operational efficiency to manage rising equipment and labor costs.

AI Generated • Aug 5, 2026

Industry

Healthcare Providers and Services

Employees

10,900

CEO

Suzanne Foster

Headquarters

Conshohocken, PA 19428, US

AHCO Financials

Key Financial Metrics (TTM)

Gross Margin

10.37%

Operating Margin

-0.31%

Net Income Margin

-7.58%

Return on Equity

-15.16%

Return on Capital

5.44%

Return on Assets

-5.26%

Earnings Yield

-29.76%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$767.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

136.34M

Volume

119

Avg. Volume

2.32M

Financials (TTM)

Gross Profit

$312.09M

Operating Income

-$9.44M

EBITDA

$290.01M

Operating Cash Flow

$583.27M

Capital Expenditure

-$485.59M

Free Cash Flow

$97.68M

Cash & ST Invst.

$43.29M

Total Debt

$2.07B

AdaptHealth Performance Analysis

AdaptHealth annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 2,970,595,00021.0%
20232023-12-31USD 3,200,177,0007.7%
20242024-12-31USD 3,260,975,0001.9%
20252025-12-31USD 3,244,857,000-0.5%
AdaptHealth sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-301.8%
Q42025-12-3140.4%
Q12026-04-10-3.1%
Q22026-06-30-9.7%
AdaptHealth annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.50-57.5%
20232023-12-31USD -5.06N/A
20242024-12-31USD 0.61N/A
20252025-12-31USD -0.52N/A
AdaptHealth sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3060.0%
Q42025-12-31-556.3%
Q12026-04-1083.6%
Q22026-06-30-725.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$740.31M

+25.1%

Gross Profit

$104.21M

+293.3%

Gross Margin

14.08%

N/A

Market Cap

$767.62MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$70.42K

N/A

Employees

10,900

N/A

Net Income

-$133.93M

-1012.7%

EBITDA

-$16.18M

-110.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$43.29M

-36.9%

Total Debt

$2.07B

+5.9%

Accounts Receivable

$390.39M

-0.8%

Inventory

$105.48M

-29.1%

Long Term Debt

$2.00B

+5.9%

Short Term Debt

$63.49M

+6.4%

Return on Assets

-5.26%

N/A

Return on Invested Capital

-0.26%

N/A

Free Cash Flow

-$20.94M

-128.6%

Operating Cash Flow

$145.30M

-10.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
INMDInMode Ltd.
$15.10+0.27%
BBNXBeta Bionics, Inc.
$19.73+3.57%
AMPHAmphastar Pharmaceuticals, Inc.
$21.52-0.37%
CVACCureVac N.V.
$4.66+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$111.16-0.08%
SOXSDirexion Shares ETF Trust - Direxion Daily Semiconductor Bear 3x ETF
$50.75+0.08%
IBITiShares Bitcoin Trust
$44.64+0.02%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$40.19+0.03%

Questions About AHCO

What is the current price of AdaptHealth?

AdaptHealth is trading at $5.63 per share.

What is the 52-week range for AdaptHealth?

Over the past 52 weeks, AdaptHealth has traded between $5.21 and $13.43.

How much debt does AdaptHealth have?

As of the most recent reporting period, AdaptHealth reported total debt of $2.07B.

How much cash does AdaptHealth have on hand?

AdaptHealth reported $43.29M in cash and cash equivalents in its most recent financial results.

What is AdaptHealth’s dividend yield?

AdaptHealth does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.